Physician profile
David Hu
NPI 1467646984
$3,571.33
in general payments reported to CMS, 2019-2025
19 companies · $876 in 2025
The $876 reported for 2025 was more than what 76% of Otolaryngology providers received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $242 · 2020: $207 · 2021: $414 · 2022: $1,349 · 2023: $308 · 2024: $176 · 2025: $876.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,325 · Education: $34.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,325.34 |
| Education | $34.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $756.71 | 2019-2025 | Scopis Ent, Latera |
| Genzyme Corporation | $541.94 | 2020-2025 | |
| Glaxosmithkline, LLC. | $520.25 | 2022-2025 | Nucala |
| Inspire Medical Systems, INC. | $457.48 | 2022 | |
| Aerin Medical INC. | $316.69 | 2019-2025 | |
| Regeneron Healthcare Solutions, INC. | $307.16 | 2020-2025 | Dupixent, Libtayo |
| Optinose US, INC. | $189.79 | 2020-2022 | |
| Medtronic, INC. | $149.95 | 2021-2022 | |
| Amgen INC. | $65.52 | 2022-2025 | Tezspire |
| Merck Sharp & Dohme LLC | $50.36 | 2023-2025 | Keytruda |
| Intersect Ent, INC. | $44.91 | 2019-2020 | |
| Kaleo, INC. | $37.93 | 2020 | |
| Neurent Medical Limited | $31.12 | 2025 | Neuromark System, Neuromark Radiofrequency Console |
| Davol INC. | $19.78 | 2022 | |
| Cochlear Americas | $18.50 | 2024 | Cochlear Nucleus Ci632 Cochlear Implant With Slim Modiolar Electrode, Osia Osi300 Implant, Baha |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ars Pharmaceuticals Operations, INC. | $17.05 | 2025 | Neffy |
| Getinge USA Sales, LLC | $16.39 | 2025 | Ultima Activator II Drive Mechanism |
| Acclarent, INC | $16.32 | 2019 | |
| Genentech USA, INC. | $13.48 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Hu listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.